Cannabis, CBD, Vape Products See Uptick in Sales in Thriving Legal Marijuana Markets

Wednesday, May 3, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

PALM BEACH, Florida, May 3, 2017 /PRNewswire/ --

As cannabis

continues to strengthen its grip on economies around the globe, industry leaders are capitalizing through product development and creating unique solutions for cannabis users when it comes to vaporizing and CBD-oil. Cannabis products appear to be poised
for a rather strong 2017 as demand continues to rise for Industry Companies such as: Ubiquitech Software Corp. (OTC: UBQU), GB Sciences, Inc. (OTC: GBLX), Medical Marijuana, Inc. (OTC: MJNA), Acology Inc. (OTC: ACOL)

Ubiquitech Software Corp.  (OTC: UBQU) announced to shareholders last week that its subsidiary HempLife Today™, an innovative and growing Company offering the finest CBD (Cannabidiol), products derived from Hemp, has had two record breaking sales weekends in a row for its CannazALL™ line of CBD products, and the Company expects this upward trend to continue. Sales of CannazALL™ CBD products saw an increase of over 50% from April 13th to April 18th, and an increase of over 55% - April 20th through the 24th.

Vapor Group, Inc ., trading on the OTC under the Symbol VPOR, announced today that the production of Easy Grinder™ has begun and that its subsidiary, Total Vapor, Inc., will begin shipping orders this month. Read this and more news for Vapor Group at:

The Company previously announced that it had delayed production until several improvements could be made to the original Easy Grinder™ design, and that all customers would receive the enhanced version at no additional cost. Due to the delay, the Company increased its inventory stocking order so that customers ordering by the end of May will have their Easy Grinder™ shipped quickly.

Dror Svorai, President of the Company, stated, "We are very excited about this improved Easy Grinder™! It's truly amazing in that it can produce a much finer ground product - wet or dry - because of its cleverly configured blades and much more powerful motor and battery. It is simple to use, manufactured to high quality standards of performance and reliability, and exceeds the capabilities of anything comparable on the market." He added, "Each week our pre-sales of Easy Grinder™ from consumers and distributors alike have escalated such that we find ourselves constantly revising upward our revenue and profit forecasts. As a result, we believe 2017 will vastly surpass any of the Company's prior years' performance."

GB Sciences, Inc.  (OTCQB: GBLX) closed up over 13% at $0.27 on Tuesday by the market close. GB Sciences and Arizona-based Kush Cups recently signed an agreement to produce cannabis-infused products in the state of Nevada. GB Sciences utilizes advanced propagation technology, raw tissue, and grows in medical-grade clean rooms, so that the venture is ensured of consistent cannabis ingredients for its infused products. "We've paired with a strong partner here. We are confident GB Sciences will distribute the Kush Cups successfully in Nevada," said Rick Chavez, founder of Kush Cups Nevada LLC

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, yesterday announced financial results for the quarter and year ending December 31, 2016, and provided an overview of recent operational highlights. The Company continued to show strong growth throughout the year, as 2016 revenue increased quarter over quarter by 66% from Q1 to Q4 and Net Comprehensive Income increased to $171,387,975 which is 731% higher than 2015. The company had net revenue of $8,003,943 in 2016. "As the No. 7 investor in Medical Marijuana, Inc., I'm proud to say we are on course for a historic 2017," Medical Marijuana, Inc. CEO Dr. Stuart Titus said. "From groundbreaking research conducted on the Company's products in Latin America during 2016, to substantial market cap growth by the Company's major investments and the development of new proprietary molecules and IP by portfolio companies, shareholders have a lot to be excited about."

Acology Inc.  (OTC: ACOL) announced this week that they have entered negotiations to purchase EZ Health Solutions. The purpose of the acquisition is to create a new division in the company that will move strongly into the CBD extract industry. Industry experts predict that associated hemp and CBD extract sales will top $1.8B by 2020 with CBD-associated products experiencing a yearly 53% AGR. Acology management intends to quickly add this new division to the company, joining their pharmaceutical container, hydroponics, printing and advertising divisions.

DISCLAIMER: (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  MNU is NOT affiliated in any manner with any company mentioned herein.  MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  MNU is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed MNU has been compensated six thousand nine hundred dollars for news coverage of the recent, current and upcoming press releases issued by Vapor Group, Inc. by a non-affiliated third party.  MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Contact Information: Media Contact +1(561)325-8757


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store